Table 1.
Clinicopathologic characteristics of 52 patients undergoing total pancreatectomy
| Variable | No. of patients |
| Mean age ± SD (yr) | 60.3 ± 9.0 |
| Sex (male) | 32 |
| Pathology | |
| Adenocarcinoma | 43 |
| Cystadenocarcinoma | 2 |
| Invasive IPMN | 4 |
| Acinar adenocarcinoma | 1 |
| Adenosquamous carcinoma | 1 |
| Renal cell carcinoma metastasis | 1 |
| Tumor location | |
| Head | 28 |
| Corpus | 15 |
| Tail | 3 |
| > 1 location | 6 |
| Median primary tumor size (IQR) (cm) | 4.7 (3.0-6.0) |
| Venous invasion | 26 |
| Lymph node invasion | 18 |
| Splenectomy | 11 |
| Operative time (IQR) (min) | 472.5 (421.3-548.8) |
| Operative arrangement | |
| Planned | 20 |
| Unplanned | 32 |
| Postoperative complication1 | |
| Gastroplegia | 4 |
| Gastrointestinal or abdominal hemorrhage bleeding | 1 |
| Pneumonia | 14 |
| Abdominal infection | 9 |
| Hepatic failure | 1 |
| Respiratory failure | 1 |
| Length of postoperative hospital stay (IQR) (d) | 12.0 (10.0-17.8) |
| Neoadjuvant treatment | 14 |
| Adjuvant treatment | 52 |
| Median recurrence-free time (IQR) (mo) | 4.7 (2.7-13.6) |
| Median survival time (IQR) (mo) | 20.9 (10.2-51.0) |
| 1-year survival (%) | 63.4 |
| 3-year survival (%) | 24.2 |
| 5-year survival (%) | 12.5 |
1
Five patients had two complications simultaneously, and one patient had three complications simultaneously. IPMN: Intraductal papillary mucinous neoplasms.